Evidence map›Paper›PMID 42671324›Full record

ArticleClinical and translational medicine2026

Beyond immune activation: Nitric oxide-mediated tumour microenvironment remodeling operates as a new paradigm for cancer immunotherapy.

Xie Xinxin, Xu Shuyu, Liang Xiaolong

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xie XinxinBeijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Ultrasound, Peking University Third Hospital, Beijing, People's Republic of China.
Xu ShuyuBeijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Ultrasound, Peking University Third Hospital, Beijing, People's Republic of China.
Liang XiaolongBeijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Ultrasound, Peking University Third Hospital, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0001-7299-3329

Funding

Beijing Natural Science Foundation JQ22024Beijing Natural Science Foundation L232087National Natural Science Foundation of China 32271443
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42671324
PMCPMC13528614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.